Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

2.570 -0.080 (-3.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,002,864
Open 2.610
Bid (Size) 2.600 (2)
Ask (Size) 2.670 (15)
Prev. Close 2.650
Today's Range 2.570 - 2.665
52wk Range 1.250 - 3.370
Shares Outstanding 304,811,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agenus to Participate in February Investor Conferences
From Agenus Inc.
Via Globe NewsWire
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
 
Via Benzinga

Performance

YTD
+7.08%
+7.08%
1 Month
+7.31%
+7.31%
3 Month
+7.53%
+7.53%
6 Month
-1.53%
-1.53%
1 Year
+2.80%
+2.80%

More News

Read More
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
From Agenus Inc.
Via Globe NewsWire
Looking Into Agenus's Return On Capital Employed
Via Benzinga
Why Shares of Agenus Rose 12.5% on Friday
Via The Motley Fool
Agenus (AGEN) Q3 2022 Earnings Call Transcript
Via The Motley Fool
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
Via Benzinga
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
From Agenus Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
From Agenus Inc.
Via Globe NewsWire
7 Hot Stocks to Book Profits In Before 2023
Via InvestorPlace
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
From Agenus Inc.
Via Globe NewsWire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
From Agenus Inc.
Via Globe NewsWire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
From Agenus Inc.
Via Globe NewsWire
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
10 Best Medical Stocks Under $5
Via Talk Markets
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
From Agenus Inc.
Via Globe NewsWire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
From Agenus Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.